Unjha Formulations Ltd.

Name: Unjha Formulations Ltd. Share Price Today, Stock Analysis
Brand: Unjha Formulations Ltd.

Stock Card

BSE: 531762

₹26.00

₹0.75 (2.97%)

As on 26-Aug-2026IST

Market cap

₹12 Cr

Revenue (TTM)

₹15 Cr

P/E Ratio

24.8

P/B Ratio

2.9

Div. Yield

0 %

Unjha Formulations Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 26.00 High: 26.50

52 Week Range

Low: 17.52 High: 29.50

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹0 Cr
ROE

20.2 %
ROCE

27.5 %
Industry P/E

37.71
EV/EBITDA

11.4
Debt to Equity

0
Book Value

₹8.9
EPS

₹1
Face value

10
Shares outstanding

4,480,500

10 Years Aggregate

CFO

₹2.33 Cr

EBITDA

₹4.41 Cr

Net Profit

₹3.20 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Unjha Formulations	4.0	9.2	30.0	5.6	25.8	24.1	10.8
BSE Healthcare	17.7	3.5	7.6	14.1	22.7	14.7	12.2

As on 26-Aug-2026

Company	2025	2024	2023	2022	2021	2020	2019
Unjha Formulations	-18.4	77.6	6.2	42.0	22.5	15.3	-6.8
BSE Small Cap	-6.6	29.0	47.5	-1.8	62.8	32.1	-6.8
BSE Healthcare	-3.3	43.1	37.0	-12.1	20.9	61.4	-3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Unjha Formulations	26.0	11.7	15.4	0.5	4.7	11.5	24.8	2.9
Acutaas Chemicals	3,257.8	26,706.0	1,461.8	387.4	34.5	25.2	69.1	15.4
Caplin Point Lab	2,516.3	19,147.4	2,287.3	678.1	31.4	19.7	28.8	5.1
Emcure Pharmaceuticals	1,862.3	35,330.5	9,683.5	1,019.0	15.7	21.3	34.9	6.7
Granules India	828.2	20,546.1	5,632.3	662.4	17.2	14.3	31	4.2
Neuland Lab	23,545.0	30,223.6	2,371.8	497.8	28.0	28.5	60.7	15.0
Pfizer	4,802.5	21,951.1	2,569.8	735.2	34.4	19.2	29.9	5.0
Piramal Pharma	211.3	28,151.4	9,205.3	-371.8	1.7	-3.8	--	3.5
Rubicon Research	1,818.8	30,043.2	1,935.8	288.2	20.6	29.8	104.2	22.4
Wockhardt	1,882.1	30,552.6	3,564.0	414.0	15.3	8.4	74.7	6.1

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Unjha Formulations

Unjha Formulations Limited manufactures and sells ayurvedic products in India. The company offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron and Fibron SF... names, as well as natural fiber drink products. It also exports its products. The company was incorporated in 1994 and is based in Sidhpur, India. Read more

Incorporated

1994
Chairman

Jashodaben S Patel
Managing Director

Krutiben M Patel
Headquarters

Sidhpur, Gujarat
Website

www.unjhaformulations.com

FAQs for Unjha Formulations

What is the current share price of Unjha Formulations Ltd Today?

The share price of Unjha Formulations Ltd is ₹26.00 (BSE) as of 26-Aug-2026 IST. Unjha Formulations Ltd has given a return of 25.83% in the last 3 years.

What is the current PB & PE ratio of Unjha Formulations Ltd?

The P/E ratio of Unjha Formulations Ltd is 24.79 times as on 26-Aug-2026, a 34 discount to its peers’ median range of 37.71 times.
The P/B ratio of Unjha Formulations Ltd is 2.91 times as on 26-Aug-2026, a 45 discount to its peers’ median range of 5.27 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2026	12.90	2.37
2025	23.99	3.11
2024	30.47	3.10
2023	19.83	2.28
2022	16.66	1.94

What is the 52 Week High and Low of Unjha Formulations Ltd?

The 52-week high and low of Unjha Formulations Ltd are Rs 29.50 and Rs 17.52 as of 27-Aug-2026.

What is the market cap of Unjha Formulations Ltd?

Unjha Formulations Ltd has a market capitalisation of ₹ 12 Cr as on 26-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Unjha Formulations Ltd?

Before investing in Unjha Formulations Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.